CATALOGO DEI PRODOTTI DELLA RICERCA

PIGHI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.985
EU - Europa 2.439
AS - Asia 2.074
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 126
OC - Oceania 5
Totale 8.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.892
RU - Federazione Russa 1.163
SG - Singapore 924
IT - Italia 509
CN - Cina 333
BR - Brasile 225
HK - Hong Kong 215
VN - Vietnam 208
BD - Bangladesh 146
FR - Francia 127
DE - Germania 123
GB - Regno Unito 111
IE - Irlanda 98
KR - Corea 75
SE - Svezia 69
CA - Canada 58
FI - Finlandia 54
ES - Italia 41
IN - India 33
PL - Polonia 32
NL - Olanda 31
TG - Togo 31
BJ - Benin 29
NG - Nigeria 22
AT - Austria 21
JP - Giappone 20
TN - Tunisia 18
ID - Indonesia 17
MX - Messico 17
AR - Argentina 16
PH - Filippine 13
TR - Turchia 12
IQ - Iraq 11
LT - Lituania 9
PT - Portogallo 9
UA - Ucraina 9
VE - Venezuela 9
BE - Belgio 8
EC - Ecuador 8
TW - Taiwan 8
ZA - Sudafrica 8
CO - Colombia 7
PK - Pakistan 7
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BH - Bahrain 5
IR - Iran 5
PE - Perù 5
DK - Danimarca 4
DZ - Algeria 4
MA - Marocco 4
PY - Paraguay 4
TH - Thailandia 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
CL - Cile 3
CR - Costa Rica 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
Totale 7.903
Salva come PNG Salva come JPEG
Città #
Singapore 529
Dallas 469
San Jose 453
Ashburn 418
Moscow 376
Chandler 244
Hong Kong 208
Council Bluffs 163
Verona 121
The Dalles 97
Dublin 93
Milan 93
Ho Chi Minh City 77
Beijing 68
Los Angeles 61
Munich 53
Hanoi 50
Buffalo 48
New York 45
London 40
Columbus 33
Santa Clara 32
Lomé 31
Cotonou 29
Rome 29
Seattle 29
Madrid 27
Redondo Beach 26
Helsinki 25
Warsaw 23
Lawrence 22
Princeton 22
São Paulo 22
Abuja 20
Amsterdam 20
Redmond 20
Seoul 20
Boston 18
Sindelfingen 18
Turku 18
Montreal 17
Orem 17
Tokyo 17
Toronto 17
Frankfurt am Main 16
Phoenix 16
Wilmington 16
Paris 15
Vienna 14
Brooklyn 13
Jakarta 13
Denver 12
Montecchio Maggiore 12
Poplar 12
Figino 11
Haiphong 11
Houston 11
Atlanta 10
Chicago 10
Lappeenranta 10
Philadelphia 10
Tianjin 10
Chennai 9
Guangzhou 9
Nuremberg 9
Turin 9
Brussels 8
Da Nang 8
Hải Dương 8
Lisbon 8
Tunis 8
Ancona 7
Ann Arbor 7
Biên Hòa 7
Shenzhen 7
Stockholm 7
Taipei 7
Brasília 6
Catania 6
Des Moines 6
Pescantina 6
San Francisco 6
Bologna 5
Bonndorf 5
Charlotte 5
Curitiba 5
Hyderabad 5
Istanbul 5
Johannesburg 5
Mexico City 5
Naples 5
Ottawa 5
Palermo 5
Rio de Janeiro 5
Southend 5
Woodbridge 5
Wroclaw 5
Zhengzhou 5
Ankara 4
Belo Horizonte 4
Totale 4.716
Salva come PNG Salva come JPEG
Nome #
A Comparative Evaluation of the Chemiluminescence Immunoassay and ELISA for the Detection of Islet Autoantibodies in Type 1 Diabetes 260
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 195
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 184
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 172
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 172
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 170
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 163
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 159
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 158
Preanalytical Impact of Incomplete K2EDTA Blood Tube Filling in Molecular Biology Testing 156
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 156
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 148
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 148
Differential diagnosis of lymphocytosis in routine laboratory practice: the contribution of Sysmex- XN9100 147
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 145
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 143
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 140
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 138
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 136
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 132
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 130
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 130
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 130
Methadone metabolite (EDDP) crystals in urine: a case report 125
Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening 125
Improved potassium reliability in whole blood through hemolysis detection on the novel GEM Premier 7000 blood gas analyzer 123
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 122
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 120
Limitations of hemolysis-based correction for potassium measurement in hemolyzed whole blood samples 118
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 118
Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening 118
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay 115
Effect of syringe underfilling on the quality of venous blood gas analysis 115
Monoclonal gammopathy in SARS-CoV-2 infection 115
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 114
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 114
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 113
Impact of the COVID-19 pandemic on the volume of laboratory testing 113
Cellular immunity against SARS-CoV-2 depends on the serological status 111
Evaluating the accuracy of ChatGPT in classifying normal and abnormal blood cell morphology 108
Assessing Intra- and Inter-Analyzer Imprecision in Automated Hematological Laboratories 105
Analytical validation of hemolysis detection on GEM Premier 7000 105
Evaluation of the acceptability of proposed hemolysis limits for Werfen ACL-TOP 750 CTS 104
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 103
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 101
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 100
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 99
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 98
Impact of an air bubble within the syringe on test results obtained with a modern blood gas analyzer 95
Generative artificial intelligence (AI) for reporting the performance of laboratory biomarkers: not ready for prime time 93
Correlation between basal humoral immunogenicity and side effects after receiving the bivalent formulation of a mRNA-based vaccine 92
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 86
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 83
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 75
Evaluation of freely available artificial intelligence (AI) tools for diagnostic support in a complex clinical and laboratory presentations: a pilot study 73
Performance assessment of ChatGPT in classification of urine particles 73
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 71
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 70
Is mixing of blood gas syringes after collection really necessary? 70
The incremental impact of comorbidities in COVID-19-related deaths compared to patients dying from cancer or cardiovascular disease 70
Effect of exogenous lipids contamination on blood gas analysis 70
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 69
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 68
Analytical performance of the Roche Elecsys TnT hs Gen 6 immunoassay 64
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 64
Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study 63
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine 59
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations 58
Uso de una tira reactiva paraorina en la evaluación de las concentraciones de glucosa y bilirrubina en plasma en entornos con recursos limitados: un estudio de prueba de concepto 54
Evaluation of circadian rhythm of SARS-CoV-2 interferon-gamma release assay (IGRA) in healthy vaccinated individuals: a case-series 53
Intra-and inter-analyzer imprecision of cell population data on Sysmex XN-10 26
Decreased Plasma Concentration of Hydrogen Sulfide in Hospitalized COVID-19 Patients: A Novel Determinant of Mortality? 12
Predicting Iron Deficiencies Using Routine Complete Blood Cell Count Parameters: A Machine Learning Approach and Evaluation 8
Impacto de la vacunación primaria con BNT162b2 y una dosis de refuerzo homóloga en los anticuerpos IgA contra SARS-CoV-2 en profesionales sanitarios seronegativos 7
Niveles séricos de antígeno prostático específico (PSA) tras vacunación primaria con BNT162b2 6
Variación longitudinal comparativa de los anticuerpos totales, IgG e IgA contra el SARS-CoV-2 en receptores de la vacuna BNT162b2 6
Evaluating the influence of different anticoagulant blood collection tubes on the efficiency of circulating RNA extraction and Real-Time PCR quantification 6
Son los anticuerpos IgG e IgM contra los antígenos S y N del SARS-CoV-2 siempre predictores de infección previa por SARS-CoV-2? 5
Totale 8.063
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.642
article - articoli 30.029
book - libri 0
conference - conferenze 238
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 375
Totale 61.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022176 0 37 7 8 10 4 4 6 14 8 26 52
2022/2023621 36 51 58 116 31 126 23 54 63 9 29 25
2023/2024433 19 30 29 45 66 48 43 71 4 25 38 15
2024/20251.527 65 84 90 185 61 62 64 87 181 139 225 284
2025/20264.902 333 281 405 672 1.139 285 455 285 359 234 225 229
2026/2027351 102 249 0 0 0 0 0 0 0 0 0 0
Totale 8.063